Ovarian Cancer: Markers of Response

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Gynecologic Cancer

• Publication date

  2009-09-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/IGC.0b013e3181c2aeb5PMID 19955910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Survival-Related Profile, Pathways, and Transcription Factors in Ovarian Cancer

  2009cited by this paper
• Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study.

  2009cited by this paper
• Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

  2009cited by this paper
• Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers.

  2009cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers A Gynecologic Oncology Group study.

  2008cited by this paper
• Genomic analysis of epithelial ovarian cancer

  2008cited by this paper
• Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer.

  2008cited by this paper
• Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas  

  2008cited by this paper
• Forensic bioinformatician aims to solve mysteries of biomarker studies.

  2008cited by this paper
• Utilization of genomic signatures to direct use of primary chemotherapy.

  2008cited by this paper
• Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

  2008cited by this paper
• A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.

  2008cited by this paper
• Microarrays: retracing steps

  2007cited by this paper
• An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

  2007cited by this paper
• Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.

  2007cited by this paper
• Klotho protein promotes adipocyte differentiation.

  2006cited by this paper
• The methionine salvage pathway compound 4-methylthio-2-oxobutanate causes apoptosis independent of down-regulation of ornithine decarboxylase.

  2006cited by this paper
• Oncogenic pathway signatures in human cancers as a guide to targeted therapies

  2006cited by this paper
• Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication.

  2006cited by this paper
• A novel cis-acting element in Her2 promoter regulated by Stat3 in mammary cancer cells.

  2006cited by this paper
• Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.

  2006cited by this paper
• Clinical characteristics and prognosis of mucinous tumors of the ovary.

  2006cited by this paper
• Diagnosis and Management of Epithelial Ovarian Cancer

  2006cited by this paper
• Expression Profiling of Mucinous Tumors of the Ovary Identifies Genes of Clinicopathologic Importance

  2006cited by this paper
• Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

  2005cited by this paper
• HER2/neu Oncoprotein Overexpression in Epithelial Ovarian Cancer: Evaluation of its Prevalence and Prognostic Significance

  2005cited by this paper
• Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

  2005cited by this paper
• Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers

  2005cited by this paper
• Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.

  2005cited by this paper
• Recurrent ovarian cancer.

  2005cited by this paper
• Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.

  2005cited by this paper
• American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays.

  2004cited by this paper
• DNA Polymerase ζ Regulates Cisplatin Cytotoxicity, Mutagenicity, and The Rate of Development of Cisplatin Resistance

  2004cited by this paper
• FOXO4 Is Acetylated upon Peroxide Stress and Deacetylated by the Longevity Protein hSir2SIRT1*

  2004cited by this paper
• Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control

  2004cited by this paper
• Recurrent Ovarian Cancer

  2004cited by this paper
• Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis

  2004cited by this paper
• In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancer.

  2004cited by this paper
• Gene expression profiling of ErbB receptor and ligand-dependent transcription

  2004cited by this paper
• Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells.

  2003cited by this paper
• Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.

  2003cited by this paper
• Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.

  2003cited by this paper
• Pathology of ovarian carcinoma.

  2003cited by this paper
• Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains.

  2003cited by this paper
• Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression

  2003cited by this paper
• Long‐term follow‐up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer

  2003cited by this paper
• Regulation of angiogenesis by the aging suppressor gene klotho.

  2002cited by this paper
• Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary study.

  2002cited by this paper
• Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development.

  2002cited by this paper
• Structure and function of the type 1 insulin-like growth factor receptor

  2000cited by this paper
• Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.

  2000cited by this paper
• A Human REV7 Homolog That Interacts with the Polymerase ζ Catalytic Subunit hREV3 and the Spindle Assembly Checkpoint Protein hMAD2*

  2000cited by this paper
• Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis

  2000cited by this paper
• Polyamines

  1999cited by this paper
• The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma.

  1996cited by this paper
• OVARIAN SURFACE EPITHELIUM, OVULATION AND CARCINOGENESIS

  1996cited by this paper
• 5'-Deoxy-5'-methylthioadenosine phosphorylase and p16INK4 deficiency in multiple tumor cell lines.

  1995cited by this paper
• Vesicular stomatitis virus glycoprotein is sorted and concentrated during export from the endoplasmic reticulum.

  1994cited by this paper
• Cancer of the ovary.

  1994cited by this paper
• Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.

  1994cited by this paper
• Cancer of the ovary.

  1993cited by this paper
• Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

  1990cited by this paper
• Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments.

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Polyamines.

  1984cited by this paper

• STAU1-mediated CNBP mRNA degradation by LINC00665 alters stem cell characteristics in ovarian cancer

  2024cites this paper
• Integrated analysis of cancer stem cells-associated lncRNA-miRNA-mRNA network for ovarian cancer via microarray and Gene Expression Omnibus database

  2020cites this paper
• Identification of modules and hub genes associated with platinum-based chemotherapy resistance and treatment response in ovarian cancer by weighted gene co-expression network analysis

  2019cites this paper
• Pancreatic and Ovarian Cancer Biomarkers

  2019cites this paper
• Genomic Applications in Ovarian Cancer

  2018cites this paper
• The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer

  2016cites this paper
• Genomic Applications in Epithelial Ovarian Malignancies

  2015cites this paper
• Ovarian cancer: targeting the untargetable.

  2014cites this paper
• Randomized reverse marker strategy design for prospective biomarker validation

  2014cites this paper
• Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer.

  2014cites this paper
• Discrete mixture modeling to address genetic heterogeneity in time-to-event regression

  2014cites this paper
• Pancreatic and ovarian cancer biomarkers

  2014cites this paper
• The significance of the pattern of serum CA125 level ascent to above the normal range in epithelial ovarian, primary peritoneal and tubal carcinoma patients.

  2013cites this paper
• Genomic Landscape of Ovarian Cancer

  2013cites this paper
• Multiparameter flow cytometric immunophenotyping of epithelial cells in effusions. Technical improvements and apoptosis measurement.

  2013cites this paper
• Ascites analysis by a microfluidic chip allows tumor-cell profiling

  2013cites this paper
• Description des phénotypes cliniques des patientes diagnostiquées pour un cancer de l'ovaire de type épithélial à partir d'un entrepôt de données cliniques : un soutien pour la génomique fonctionnelle

  2013cites this paper
• Cancer Genomics

  2013influential citation
• Discrete mixture regression models for heterogenous time-to-event data : Cox assisted clustering

  2012cites this paper
• The role of tandem duplicator phenotype in tumour evolution in high‐grade serous ovarian cancer

  2012cites this paper
• Evolution of platinum resistance in high-grade serous ovarian cancer.

  2011cites this paper
• Progression-Free Survival in Ovarian Cancer Is Reflected in Epigenetic DNA Methylation Profiles

  2011cites this paper
• Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers.

  2011cites this paper
• miRNA control of apoptotic programs: focus on ovarian cancer

  2011cites this paper
• Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study.

  2011cites this paper